Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-272-0 | CAS number: 7473-98-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From Mar 8, 1999 to May 18, 1999
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 999
- Report date:
- 1999
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- When this study was performed, the LLNA did not yet exist.
Test material
- Reference substance name:
- 2-hydroxy-2-methylpropiophenone
- EC Number:
- 231-272-0
- EC Name:
- 2-hydroxy-2-methylpropiophenone
- Cas Number:
- 7473-98-5
- Molecular formula:
- C10H12O2
- IUPAC Name:
- 2-hydroxy-2-methyl-1-phenylpropan-1-one
- Details on test material:
- - Name of test material (as cited in study report): TKA 40052 (DAROCUR 1173)
- Lot/batch No.: 11/98
- Expiration date of the lot/batch: February 29, 2000
- Storage condition of test material: in the original container at room temperature
- Purity:: 99.6%
- Physical state: colorless liquid
-Test solutions were prepared under light protection
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Albino (Ibm:GOHI; SPF quality guinea pigs, synonym: Himalayan spotted)
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: RCC LTD. Biotechnology & Animal Breeding Division, Wölferstrasse 4, CH-4414 Füllinsdorf, Switzerland)
- Age at study initiation: 4-6 weeks
- Weight at study initiation: 290-345 g
- Housing: Individually in Makrolon type-4 cages with standard softwood bedding ("Lignocel", Schill AG, CH-4132, Muttenz)
- Diet (e.g. ad libitum): Pelleted standard Nafag Ecosan 845 25W4, Batchs nos. 103/98, 112/98 and 23/99), guinea pig breeding/maintenance diet ("Nafag", Nähr- und Futtermittel AG, CH-9202 Gossau) ad libitum
- Water (e.g. ad libitum): Community tap water from Füllinsdorf ad libitum
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22-28
- Humidity (%): 32-84
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12 (Fluorescent "Gold" lamps (Sivania Gold F40T1260))
IN-LIFE DATES: From: March 8, 1999 To: May 18, 1999
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: FCA/saline 1:1 (intradermal)
- Concentration / amount:
- 0% test material
0.3 ml - Day(s)/duration:
- Day 1
- Adequacy of induction:
- not specified
- Route:
- intradermal and epicutaneous
- Vehicle:
- polyethylene glycol
- Concentration / amount:
- 5% test material
0.3 ml - Day(s)/duration:
- Day 1
- Adequacy of induction:
- not specified
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: FCA/saline 1:1 (intradermal)
- Concentration / amount:
- 5 % test material
0.3 ml - Day(s)/duration:
- Day 1
- Adequacy of induction:
- not specified
Challenge
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- polyethylene glycol
- Concentration / amount:
- 25% test material
0.2 ml - Day(s)/duration:
- Day 22 (48 hours)
- Adequacy of challenge:
- not specified
- No. of animals per dose:
- Control: 5
Treatment: 10 - Details on study design:
- RANGE FINDING TESTS:
INTRADERMAL INJECTIONS:
Four intradermal injections (0.1 ml/site) of a 1:1 (v/v) mixture of Freund's Complete Adjuvant/physiological saline were made into the shaved neck of one guinea pig. One week later intradermal injections (0.1 ml/site) were made into the clipped flank of the same guinea pig at concentrations of 5, 3 and 1 % of the test article in PEG 400.
Dermal reactions were assessed 24 hours later. All three tested concentrations resulted in dermal reactions with a score of 2.
Based on the results and the provisions of OECD guideline 406, a test article concentration of 5 % was selected for intradermal induction in the main study.
EPIDERMAL APPLICATIONS:
Four intradermal injections (0.1 ml/site) of a 1:1 (v/v) mixture of Freund's Complete Adjuvant/physiological saline were made into the shaved neck of two guinea pigs. One week later both flanks of each of the guinea pigs were clipped and shaved just prior to the application. Thereafter 4 patches of filter paper (3x3 cm) were saturated with the test article at A = 100 %, B = 75 %, C = 50 % and D = 25 % and applied to the clipped and shaved flanks. PEG 400 was used for the dilutions. The volume of test article preparation applied was approximately 0.2 ml. The patches were covered by a strip of aluminum foil and firmly secured by elastic plaster wrapped around the trunk and covered with impervious adhesive tape. This procedure ensured the intensive contact of the test article. The dressings were removed after an exposure period of 24 hours.
Approximately 21 hours after removal of the dressing the application site was depilated with an approved depilatory cream (VEET Cream, Reckitt & Colman AG, CH-4123 Allschwil) in order to visualize any resulting erythema.
The depilatory cream was placed on the patch sites euid surrounding areas, and left on for 3-5 minutes. It was then thoroughly washed off with a stream of warm, running water. The animals were then dried with a disposable towel, and returned to their cages.
The reaction sites were assessed approximately 24 and 48 hours after removal of the bandage for erythema and oedema according to the method of Magnusson and Kligman.
Based on the results obtained the concentration selected for induction and challenge in the main study was 100 % and 25 %, respectively (see table 1)
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 4
- Exposure period: 3 weeks
-First induction period - Test groups: 3 pairs of intradermal injections were made at the border of a 4X6 cm area in the hair-free clipped region a follows:
1) 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
2) The test article, at 5 % in PEG 400.
3) The test article at 5 % in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
- Control group:
1) 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
2) PEG 400
3) 1:1 (w/w) mixture of PEG 400 in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline.
-Second induction period
One week after the injections, the scapular area (approximately 6 x 8 cm) was again clipped and shaved free of hair prior to the application. A 2 x 4 cm patch of filter paper was saturated with the undiluted test article and placed over the injection sites of the test animals. The volume of test article preparation applied was approximately 0.3 ml. The patch was covered with aluminum foil and firmly secured by an elastic plaster wrapped around the trunk of the animal and secured with impervious adhesive tape. The occlusive dressings were left in place for 48 hours. The epidermal application procedure described ensures intensive contact of the test article.
The guinea pigs of the control group were treated as described above with PEG 400 only, also applied at a volume of approximately 0.3 ml.
The reaction sites were assessed 24 and 48 hours after removal of the bandage for erythema and oedema according to the method of Magnusson and Kligman
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 22
- Exposure period: 24 hours
- Test groups: 25% (same method as second induction period)
- Control group: PEG (same method as second induction period)
- Volume applied: 0.2 mL
- Site: dorsal
- Evaluation (hr after challenge): 24 and 48h after removal of the bandage - Challenge controls:
- The animals of the control group were intradermally induced with PEG 400 and FCA/physiological saline and epidermally induced with PEG 400 under occlusion.
- Positive control substance(s):
- yes
- Remarks:
- 2-MERCAPTOBENZOTHIAZOLE
Results and discussion
- Positive control results:
- In this study 90 % (at the 24-hour reading) and 100 % (at the 48-hour reading) of the animals of the test group were observed with very slight to moderate/severe erythematous reactions after treatment with a non-irritant 2-MERCAPTOBENZOTHIAZOLE concentration of 10 % in mineral oil.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Draize scores for erythema and edema were 0 in all animals.
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: Draize scores for erythema and edema were 0 in all animals..
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- Draize scores for erythema and edema were 0 in all animals.
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: Draize scores for erythema and edema were 0 in all animals..
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- Draize scores for erythema and edema were 0 in all animals.
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: Draize scores for erythema and edema were 0 in all animals..
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- Draize scores for erythema and edema were 0 in all animals.
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: Draize scores for erythema and edema were 0 in all animals..
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 10%
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Clinical observations:
- The animals of the test group were observed with very slight to moderate/severe erythematous reactions after treatment with a non-irritant 2-MERCAPTOBENZOTHIAZOLE concentration of 10 % in mineral oil
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 10%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Clinical observations:
- The animals of the test group were observed with very slight to moderate/severe erythematous reactions after treatment with a non-irritant 2-MERCAPTOBENZOTHIAZOLE concentration of 10 % in mineral oil
Any other information on results incl. tables
Skin effects after intradermal induction:
- Control and test groups:
The expected and common findings were observed after the different applications using FCA intradermally and consisted of erythema, oedema, necrotizing dermatitis, encrustation and exfoliation of encrustation.
Skin effects after epidermal induction:
- Control group:
No erythematous or oedematous reaction was observed in the animals treated with PEG 400 only.
- Test group:
Discrete/patchy erythema was observed in 5 (at the 24 -hour reading) and 6 (at the 48 -hour reading) out of 10 animals after treatment with the undiluted test article.
Skin effects after the challenge:
- Control and test groups:
No skin reactions were observed in the animals when treated with either PEG 400 only or when treated with the test article at 25% in PEG 400.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test substance applied at a challenge concentration of 25% in PEG 400 does not cause skin sensitization in the guinea pig maximization test.
- Executive summary:
In this guideline (OECD 406) study conducted with GLP certification, the test material (EC 231-272-0) did not induce skin sensitisation in the test animals (Guinea pig). The test was conducted using the Guinea pig maximisation method, with an induction of 5% test material applied for 48 hours exposure under occlusive conditions, one week after induction injections. A challenge exposure of 25% test material was applied under occlusive conditions, 24 hour exposure, two weeks after the induction. Test animals showed no signs of sensitisation to the test material during the challenge and observation periods. Based upon the results of the test, the test material does not meet the criteria for classification under the EU Classification, Labelling, and Packaging (CLP) regulation (1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.